CEJPEK, Pavel, Petr KUGLÍK, Renata VESELSKÁ, Eva NEČESALOVÁ, Vladimíra VRANOVÁ, Jiřina RELICHOVÁ, Petr KRUPA, Jaroslav HORKÝ and Pavol VNENČÁK. Significance of molecular cytogenetic characterization of glioblastoma (Význam molekulárně cytogenetické charakteristiky glioblastomu). In Proceedings of the 13 - th Congress of Neurosurgery , EANS. Glasgow: EANS, 2007, p. 401-405. ISBN 978-88-7587-386-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Significance of molecular cytogenetic characterization of glioblastoma
Name in Czech Význam molekulárně cytogenetické charakterizace glioblastomu
Authors CEJPEK, Pavel (203 Czech Republic, guarantor), Petr KUGLÍK (203 Czech Republic), Renata VESELSKÁ (203 Czech Republic), Eva NEČESALOVÁ (203 Czech Republic), Vladimíra VRANOVÁ (203 Czech Republic), Jiřina RELICHOVÁ (203 Czech Republic), Petr KRUPA (203 Czech Republic), Jaroslav HORKÝ (203 Czech Republic) and Pavol VNENČÁK (703 Slovakia).
Edition Glasgow, Proceedings of the 13 - th Congress of Neurosurgery , EANS, p. 401-405, 5 pp. 2007.
Publisher EANS
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14310/07:00023459
Organization unit Faculty of Science
ISBN 978-88-7587-386-8
UT WoS 000251574500064
Keywords in English cytogenetics; glioblastoma
Tags cytogenetics, Glioblastoma
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Renata Veselská, Ph.D., M.Sc., učo 1260. Changed: 20/3/2008 21:43.
Abstract
The significance of cytogenetic glioblastoma characteristics of glioblastoma correlated with clinical results
Abstract (in Czech)
Význam cytogenetických charakteristik glioblastomu v korelaci s klinickými výsledky
Links
MSM0021622415, plan (intention)Name: Molekulární podstata buněčných a tkáňových regulací
Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations
OC B19.001, research and development projectName: Genová diagnostika a terapie multiformního glioblastomu (Acronym: COST)
Investor: Ministry of Education, Youth and Sports of the CR, Gene Diagnostics and Therapy of Multiform Glioblastoma
PrintDisplayed: 18/7/2024 02:41